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Abstract
Treatment for opioid use disorders is highly effective yet unavailable in many 
rural areas. “Somewhere to Go: Ensuring Access to Medication-Assisted Treatment 
in Rural Maryland” is a Robert Wood Johnson Funded Clinical Scholars project 
intended to expand the use of tele-health medication-based treatment for opioid 
use disorders services directly to rural areas in need. We demonstrated that a 
University-based substance use treatment team can successfully collaborate with a 
geographically distant rural substance use treatment clinic to provide medication-
based treatment for opioid use disorders using a HIPPA compliant telehealth 
strategy. We provide an overview of the implementation strategies our team used 
to expand overall access in different locales throughout the State of Maryland and 
beyond. We describe implementation results of a tele-health medication-based 
treatment program for opioid use disorders that focuses on implementation suc-
cesses and how to identify and overcome implementation challenges and barri-
ers. Implementation of a telemedicine approach can be challenging, but careful 
consideration and forethought can map a successful path to program development, 
operation and sustainability.
Keywords: Medication assisted treatment MAT, Medication based treatment, Opioid 
Use Disorder OUD, rural, telemedicine, telehealth, video conferencing
1. Introduction
Rural America is impacted disproportionately by illicit and prescription opioid 
misuse [1–3]. Opioids include heroin and prescription opioid drugs such as oxyco-
done, hydrocodone, hydromorphone, methadone, tramadol, codeine and fentanyl. 
Prior to the 1990s, opioid misuse was predominantly an urban phenomenon 
centered on the use of heroin. A collective push in the mid-1990’s encouraged an 
increase in the prescribing of opioids for the treatment of non-malignant pain. This 
included the American Pain Society endorsement of the subjective pain score as 
the “fifth vital sign” [4]. Furthermore, patient advocacy groups and pain special-
ists highlighted the need to aggressively “treat an epidemic” of undertreated pain. 
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Concomitantly, pharmaceutical companies initiated extensive marketing campaigns 
advocating for the use of long acting opioids such as OxyContin (Purdue Pharma, 
Stamford, CT) to treat chronic non-malignant pain. These campaigns specifically 
targeted primary care physicians, the most frequent prescribers of opioid pain 
medications. As a result, opioid prescribing in the United States skyrocketed with 
a 300 percent increase in opioid prescriptions between 1991 and 2009 [5]. By 2012, 
clinicians wrote 259 million opioid prescriptions, enough to distribute one bottle of 
opiates to each adult in the USA [6]. A direct correlation between the quantities of 
opioids prescribed and the morbidity and mortality associated with these medica-
tions is clear [7]. Since 1999, overdose deaths from opioids have quadrupled [8].
The devastating consequences of opioid misuse is particularly evident in rural 
communities. For example, the per capita overdose rates have been higher in rural 
areas, as compared to urban areas, since 2006 [9]. Factors hypothesized to contribute 
to the rise in opioid misuse in rural areas include: (1) an older population with more 
chronic pain; (2) increased occupational injury from heavy labor jobs; (3) cultural 
acceptance of the use of opioids to keep individuals working in heavy-labor occupa-
tions; (4) lack of economic opportunity resulting in unemployment and financial 
hardship; and (5) more extensive social and family networks which are the predomi-
nant networks for the distribution of prescription opioids [1, 10].
Treatment for opioid use disorders is highly effective [11, 12]. Medication-based 
treatment for opioid use disorders is the term used to describe a series of evidence-
based treatments for opioid use disorders (OUD), which includes treatment with 
regulated opiate medication in combination with psychosocial interventions. Two 
of the medications approved by the FDA for the treatment of opioid use disorder 
are methadone and buprenorphine. Both medications have demonstrated greater 
efficacy than counseling alone in decreasing opioid use, increasing retention in 
substance abuse treatment, and significantly decreasing the risk of overdose and 
death [13–15]. A recent meta-analysis confirmed that patients on methadone main-
tenance therapy for opioid use disorder had a significantly decreased risk of death 
during treatment than after cessation; the same analysis suggested buprenorphine 
is similarly effective [16].
There are numerous barriers to accessing medication-based treatment for opioid 
use disorders in rural areas. For example, methadone maintenance clinics are over-
whelmingly located in urban areas, are highly regulated by the federal government, 
and require daily attendance during the early phases of treatment [17, 18]. Clearly, 
residents in rural areas with opioid use disorders may lack the means of transporta-
tion to consistently attend methadone maintenance programs. Although buprenor-
phine treatment can be delivered in a less regulated way, which may overcome some 
of the access issues historically associated with methadone treatment, 60 percent of 
all rural counties lack a waivered provider and only two percent of buprenorphine-
waivered physicians in the US practice in small and remote rural counties [19, 20].
2. Wicked problem impact project (WPIP) description
Rural communities in America are disproportionately affected by the opioid 
epidemic, a situation reflected in the state of Maryland. From 2010 to 2015, deaths 
related to prescription and non-prescription opiate overdose in the state nearly 
tripled, with substantial increases occurring in rural communities in Western 
Maryland and the Eastern Shore in particular. Although Medication-Assisted 
Treatment (MAT), which includes the use of medications (e.g. Methadone or 
Buprenorphine) with psychosocial interventions, is a lifesaving, evidence-based 
treatment for opioid use disorders, there are numerous barriers to accessing MAT in 
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rural areas of Maryland. Factors affecting the rural population mirror those listed 
above for the larger body of the USA.
Our central project goal is to increase access to medication-assisted treatment 
to rural communities in Maryland using the telehealth model piloted in an exist-
ing treatment program (Wells House) located in Western Maryland. In order to 
advance this central goal, a small, diverse, multi-disciplinary, clinical team (Team 
JEMS) was created. Our primary team is comprised of a clinical social worker, nurse 
practitioner, and two addiction psychiatrists possessing a wealth of experience 
working in multi-disciplinary substance use settings. As our team and project have 
evolved, so has the necessity of cultivating relationships with both internal and 
external program stakeholders to help champion the cause of expanding access to 
medication-assisted treatment.
Providing increased access to evidenced-based, telehealth services to address the 
opioid crisis saves lives. “Somewhere to Go: Ensuring Access to Medication Assisted 
Treatment in Rural Maryland” is a Robert Wood Johnson Foundation-funded 
Clinical Scholars project intended to expand the use of telehealth medication-based 
treatment for opioid use disorders services directly to rural areas in need. Previous 
pilot data demonstrated that a University-based substance use treatment team can 
successfully collaborate with a geographically distant rural substance use treat-
ment clinic to provide medication-based treatment for opioid use disorders using 
a HIPPA-compliant telehealth strategy. A chart review of over 150 people receiv-
ing substance abuse services demonstrated that approximately 60% were still in 
treatment at 3 months with 94% of them being free of opioid use [21]. The goal of 
the “Somewhere to Go” project was to address the significant health disparities in a 
rural Maryland community by initiating telemedicine-based opiate addiction treat-
ment services in an area that had never previously engaged in telemedicine-based 
treatment.
3. Methods
Prior to 2015, the retirement of a rural waivered medical provider resulted in the 
loss of patient access to medication-based treatment for opioid use disorders across 
an entire region. In 2015, the University of Maryland School of Medicine’s Division 
of Addiction Research and Treatment agreed to establish a pilot program to provide 
medication-based treatment for opioid use disorders using a telemedicine format 
for a rural Western Maryland Intensive Outpatient Treatment Program (IOP). A 
series of virtual and in-person meetings that included the leadership from both the 
Division of Addiction Treatment and Research and the rural, Western Maryland 
IOP occurred. The early meetings focused on ensuring organizational compat-
ibility and establishing the telemedicine programmatic policies and procedures. 
These meetings resulted in formalized Standard Operating Procedures (SOP) that 
addressed the following areas: 1) informed consent, 2) privacy/HIPAA compliance, 
3) video conferencing security, 4) initiation of telemedicine consults, 5) patient 
scheduling, 6) urine toxicology testing, and 7) medical records. Establishment 
of the agreement allowed for the forming of the new clinic to treat rural patients 
struggling with addiction disorders.
Program coordinators at both the University of Maryland and IOP sites began 
regular meetings to facilitate communication, arrange clinical schedules, and solve 
implementation problems efficiently. The program coordinators created two blocks 
of two hours for direct patient care appointments (i.e., 45-minute time slots for new 
evaluations and 20-minute follow-up appointments). At the initial telehealth visit, a 
full diagnostic patient evaluation occurred. Based on this assessment, the University 
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of Maryland physician provided a differential diagnosis and treatment plan for 
the patient including the use of buprenorphine when indicated. At the end of each 
appointment, the physician entered clinical documentation on the University 
of Maryland electronic medical record that was electronically transferred to the 
IOP site.
The IOP coordinator made all follow-up appointments. The IOP program coor-
dinator screened patients, coordinated the appointment schedules and forwarded 
appropriate clinical information (e.g., clinical notes and results of urine toxicol-
ogy screens) to the University of Maryland program coordinator prior to each 
telehealth clinical encounter. An evaluation plan consisting of in-depth interviews 
with key stakeholders focusing on barriers and challenges occurred after about 
one year of implementation. Meetings with stakeholders are held approximately 
twice a year with the IOP program staff to discuss program operational and clini-
cal issues.
The team also pursued additional funding to support and advance our tele-
medicine-based intervention and expand the number of rural patients who could 
be served.
4. Results
Since the inception of the telehealth program in August 2015, over 500 patients 
have been treated at the initial Western Maryland IOP site and at any one time, 
approximately 100 patients are in active treatment. At the time of the writing of 
this manuscript the telehealth program had been in operation for 4 ½ years. A 
chart review of the first 175 patients treated in the program demonstrated an over 
50 percent retention rate at 3 months. Of those patients retained in the program 
for three months only 6 percent were actively using illicit opioids. While the IOP 
program incurred a small financial shortfall in supporting physician costs for the 
medication-based tele initiative, it made up for it by being able to recruit and retain 
patients in their IOP counseling program.
In 2018, our team was fortunate enough to secure additional funding of 
$210,000 via the CareFirst grant to expand the telehealth model to two underserved 
rural counties (Talbot, Dorchester) on the mid-shore of Maryland.
4.1 Stakeholder interviews: barriers and challenges to implementation
Stakeholder interviews provided insights into implementation challenges. 
Challenges fell into four broad categories: documentation, acceptance of 
medication-based treatment for opioid use disorders by IOP staff, and billing and 
regulatory issues. As each site contracted with different electronic medical record 
vendors, the primary technologic challenge was the de-novo need to design and 
create functional documentation at each site. Although this challenge was easy to 
overcome, there was an unexpected opportunity and financial cost for each site. In 
addition, integration of the two electronic medical records with the goal of improv-
ing communication between the two clinical staffs is an ongoing process. A more 
pressing challenge was the opposition of some IOP staff to use medication-based 
treatment for opioid use disorders as a “first-line” treatment approach. Many of the 
counselors in the program were trained and adhered to an abstinence model of care 
where the use of opioid agonist medication is viewed as replacing one addiction for 
another. To overcome this challenge, clinicians from the University of Maryland 
conducted several in-service trainings for the IOP staff. The IOP staff were also 
encouraged by their leadership to attend continuing education classes focused on 
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medication-based treatment for opioid use disorders. Over time, these interven-
tions lead to a “normalization” of the use of medication-assisted treatment at the 
IOP site. Billing for the services was another challenge. Although a formal business 
plan was not agreed to at the beginning of the implementation process, over time 
the two sites came together to create a “workable” billing arrangement. The result 
was for the IOP program to contract with the University for physician services and 
then the University independently billed insurance and collected revenue that was 
remitted to the IOP to cover costs. Finally, regulatory concerns associated with 
the Ryan Haight Act were an early implementation concern. The 2008 law, named 
after a California teenager who overdosed on opioids bought online without being 
formally evaluated by a physician, may in theory limit opportunities for providers 
to provide telemedicine for medication-based treatment for opioid use disorders. 
Engagement with the DEA in Maryland resulted in approval for a DEA level of 
care at the IOP site that allowed for patients to be seen via a telehealth interface and 
prescribed buprenorphine without a face-to-face encounter.
5. Discussion
5.1 Recommendations for success for other rural telemedicine initiatives
Through our experience we have found that nine areas are crucial to address 
when forming distance-based partnerships to provide care for addiction treat-
ment using a telemedicine-based approach. These nine areas requiring fore-
thought and planning include: creating the team; lead with values; be responsive 
and responsible; pilot policies and procedures; develop appointment structures; 
establish the role of substance use counselor; establish the role of the medication-
based treatment for opioid use disorders prescribing clinician; ensure medication 
prescription is safe, reliable and compliant; and create monitoring and evaluation 
systems.
5.1.1 Creating the team
Developing a nimble leadership structure with the capacity to rapidly assimilate 
and share information is critical to successful implementation. This is even more 
important when two or more organizations who may be geographically quite distant 
are engaging in partnership. Taking the time to build a culture of leadership that is 
responsible, responsive, and value-based is essential for success.
5.1.2 Lead with values
Implementation of any new project rests on a foundation of shared goals and 
values. In our experience, taking the time to describe these shared set of values is 
essential to a successful project implementation. This is especially true when imple-
menting a tele-health medication-assisted treatment program where two or more 
organizations may be working together for the first time. For example, “teamwork” 
is often a shared value that is fundamental to getting a project off the ground. Yet, 
if there is no consensus about the definition of “teamwork,” unintended misun-
derstanding based on differing organizational cultures can quickly undermine the 
implementation effort. To remedy this, we recommend organizational leadership 
discuss their organizations’ shared set of values with each other prior to project 
implementation. Values such as Teamwork; Excellence; Compassion; Integrity and 
Professionalism are good places to start.
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5.1.3 Be responsive and responsible
Using shared values can assist in shaping and defining key leadership roles 
and responsibilities. Defining these roles early in the implementation process 
can significantly reduce miscommunication and allow for more rapid organi-
zational integration. Additionally, creating a culture of shared responsibility 
that prioritizes responsiveness is extremely important. Accountability is key. 
Regular meetings, whether in-person or virtual, that are task oriented, agenda-
driven, and based on shared values can guide and drive the implementation 
process.
5.1.4 Pilot policies and procedures
Prior to the initiation of clinical operations, the team’s primary goal is to establish 
programmatic policies and procedures. Formalized Standard Operating Procedures 
(SOP) need to address the following areas: 1) informed consent, 2) privacy/HIPAA 
compliance, 3) video conferencing security, 4) initiation of telemedicine consults,  
5) patient scheduling, 6) urine toxicology testing, and 7) medical records. 
Standardized templates for documentation of the initial evaluation and follow-up 
visits is highly recommended.
5.1.5 Develop appointment structures
In our experience, appointment structures are often organizationally 
dependent. However, we recommend starting with two blocks of two-hour 
appointments. These appointment slots are allocated for direct patient care, 
with 45-minute time slots for new evaluations and 20-minute follow-up 
appointments.
5.1.6 Establish the role of substance use Counselor
Substance use counselors at the distant clinic are the fulcrum of the interven-
tion. Their job is to refer people who meet criteria for opioid use disorder and 
who demonstrate interest in medication-based treatment for opioid use disorders. 
They are responsible for scheduling appointments with the off-site medication-
based treatment for opioid use disorders prescribing clinician. They are also 
the on-site provider responsible for ensuring evidence-based substance use 
counseling is in place and ensuring that data regarding substance use treatment 
outcomes (i.e., urine toxicological screening) are appropriately maintained and 
documented.
5.1.7  Establish the role of the medication-based treatment for opioid use disorders 
prescribing clinician
The role of the medication-based treatment for opioid use disorders prescrib-
ing clinician is to complete a full diagnostic patient evaluation including medical, 
psychiatric and substance abuse histories. Using information obtained through 
this meeting and the intake notes from onsite counselors, the clinician creates 
a differential diagnosis and treatment plan for the patient including the use of 
buprenorphine when indicated. Notes and updated medication logs from each 
encounter are placed in charts at both the originating and distant site. The pre-
scribing clinician continues treatment through follow-up appointments for each 
patient.
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5.1.8 Ensure medication prescription is safe, reliable and compliant
Each site will need to be compliant with state and federal regulations. We 
strongly advise meeting with officers from the local DEA office as well as State 
authorities prior to implementation. These agencies can provide critical advice 
regarding prescribing of regulated medication, use of HIPPA compliant technolo-
gies and ensuring that all providers are legally able to provide substance use care.
5.1.9 Create monitoring and evaluation systems
It is important to create an evaluation plan that is consistent with the goals of the 
implementation. One strategy is to use both chart review and informant interviews 
of clinicians, patients, and their families to provide a complementary approach to 
understanding the challenges and success of the goals of the project.
The effectiveness of telemedicine treatment approaches among diverse popula-
tions and clinical contexts, including rural populations, is well established. Expanding 
addiction treatment for rural patients via telemedicine is an important next step to 
ensure provision of accessible, evidence-based treatments where they are most in need. 
During the last 2 years, the University of Maryland School of Medicine’s Division of 
Addiction Research and Treatment used the lessons learned from our original pilot 
program to implement several additional telemedicine sites throughout the State of 
Maryland. These programs are servicing several rural areas throughout the State of 
Maryland with good outcomes. Although issues pertaining to the implementation of a 
telemedicine program are extremely important and were the focus of this chapter, there 
are equally important issues pertaining to sustainability. The viability of our telemedi-
cine program is primarily attributable to the State of Maryland Medicaid program’s 
decision to allow both sites to be eligible for reimbursement. In our case, the University 
of Maryland School of Medicine’s Division of Addiction Research and Treatment took 
on responsibility for physician billing and passed collections onto the remote site. 
Another sustainability challenge that we encountered was transitioning patients to the 
community once stabilized on medication-based treatment for opioid use disorders. In 
keeping with the hub-and-spoke model of medication-based treatment for opioid use 
disorders administration, we collaborated with the rural county’s local health depart-
ment leadership to identify providers in the community willing to continue prescrip-
tions for patients already stabilized. This approach proved highly successful.
6. Conclusion
Our findings suggest that treatment with buprenorphine delivered by telemedicine 
to patients with opioid use disorders in a rural drug treatment program is effective. 
Implementation of a telemedicine approach can be challenging, but careful consid-
eration and forethought can map a successful path to program development, opera-
tion and sustainability. Nevertheless, initiating a new clinic and addressing areas of 
health disparity where there are no other treatment options exist requires thoughtful 
planning and careful implementation on the part of the healthcare team. Despite the 
fact that an onsite clinic had previously served the rural area, the new policies and 
procedures for the telemedicine-based treatment plan still encountered obstacles 
that needed to be addressed, including local staff acceptance of new protocols. Given 
the importance of the issue of treating addictive disorders in some of the hardest hit 
and underserved areas, it is vital to address barriers that exist even at the policy level, 
such as with the Ryan Haight Act and working with the DEA for policy change and 
program approval. With collaboration and a team-based approach challenges such 
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as these are manageable and should not deter a committed group from engaging in 
a similar venture to ameliorate health disparities in rural areas. Below are additional 
gems of insight the JEMS team discovered as they implemented their “Somewhere to 
Go” project for the Clinical Scholars National Leadership Institute.
7. Leader learning in the clinical scholars program
The JEMS team faced a significant set of challenges during their Fellowship experi-
ence and in the implementation of their Wicked Problem Impact Project. First, the relo-
cation of a team member required the team to negotiate a tangible change which had 
direct impacts on team dynamics. Early investing in team commitment and functioning 
established a sense of cohesiveness and commitment to the project, which contributed 
to team success despite this difficulty. Second, for all team members, managing work/
life balance presented challenges given the demands of the Clinical Scholars program, 
the requirements of implementing a successful Wicked Problem Impact Project, and 
the ongoing demands of both work and family obligations. Managing this balance has 
required a sustained commitment and investment in one’s project, team, and family. 
Our team members found it essential to realize value and purpose beyond the funding 
or even the project, and to recognize the potential application of our learning across 
the many dimensions of life. It was not necessarily easy to balance all of these goals and 
commitments, but each team member found it to be worthwhile just the same.
The third challenge represents the thorniest and most complex challenge of all. 
A strict interpretation of the Ryan Haight Act of 2008 had the potential to derail 
our project by casting the intervention as non-compliant with Federal rules. Given 
that opiate addiction is a politically charged topic, team members had to navigate 
some complexity with the press, who unfortunately cast the efforts in a stilted and 
dramatic light seemingly to create an enticing headline. While this unwanted pub-
licity created unanticipated consequences, stakeholders who shared the vision of 
linking individuals and families to needed care in their communities were engaged. 
Through meetings with DEA representatives, the interpretation of the rules allowed 
for this project, and other similar telemedicine-based interventions across the 
country, to be successfully implemented.
7.1 Successes
Having our team and Wicked Problem selected by the Robert Wood Johnson 
Foundation was a critical and important initial success. The experience not only 
resulted in securing funding for our project, but also provided training, support, and 
guidance on how to grow individually as Clinical Scholars but also identify ways to 
refine and improve our project. Our team was fortunate enough to secure additional 
funding via the CareFirst grant to expand the telehealth model, which was a major 
coup and yielded several positive outcomes, including: 1) supporting our projects 
ability to expand the telehealth, Suboxone model to five additional sites within the 
State of Maryland; 2) increasing the number of physicians providing telehealth direct 
care and consultation and supervision to other providers; and 3) providing an oppor-
tunity to reduce some of the stigma associated with medication-assisted treatment.
The third major success has involved the opportunity to interact, network and 
meet with a diverse group of people in the RWJF universe. Learning about the vast 
array of wicked problems being addressed by other teams and their efforts to tackle 
and impact those problems has enriched our own perspective on the issues we face 
as a team and as individuals. Engagement in this process has facilitated personal and 
professional growth which transcends our wicked problem.
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7.2 Lessons learned
Creating a team founded in shared values, informed by nimble leadership with 
the capacity to assimilate and share information rapidly, is critical for implementa-
tion. We highly recommend ongoing stakeholder meetings to facilitate communica-
tion, remedy potential problems and enhance evaluation of outcomes. We believe 
cultural sensitivity and community engagement is crucial for successful sustain-
ability in rural communities. Our team learned that community leadership works 
best when shared and allows for the voices of multiple stakeholders to be heard. 
Community leadership requires listening that evolves to greater understanding of 
the perspective of others. Community leadership requires involvement of the com-
munity in order to cultivate a shared vision, shared responsibilities and shared roles 
in addressing the problems at hand.
Working within a community context is fraught with both landmines and 
inroads, risk and benefits. In Clinical Scholars we learned from our colleagues at 
Community-Campus Partnerships for Health (CCPH) that following the principle 
of “developing partnerships that balance power and share resources equitably 
among partners” is a good place to start. The CCPH principle referenced is the 
antithesis of the maxim “He who has the gold makes the rules” and hopefully helps 
guard against stepping on some of the potential landmines by promoting thought 
diversity and inclusiveness, and avoiding the dangers or disruptions associated with 
group think. In order to truly balance power and share resources equitably requires 
active communication and engagement to be successful.
8. Toolkit
A comprehensive toolkit can be found at https://clinicalscholarsnli.org/
community-impact.
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